Ranolazine
NDC 60687-549, Ranolazine, tablet, extended release, from American Health Packaging.
- Product NDC
- 60687-549
- Status
- Listed
- Labeler
- American Health Packaging
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210054
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60687-549 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RANOLAZINE500 mg/1
Pharmacologic classes
Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60687-549-21 | 60687054921 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-549-21) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (60687-549-11) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/90c5a0c2-542c-467e-9c0c-ef320534c560NADAC price for package 60687054921
GET /v1/drugs/nadac/60687054921
Use it
Look up 60687-549 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60687-549 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60687-549. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.